![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bruns L.A.
Publisher: Adis International
ISSN: 1174-5878
Source: Pediatric Drugs, Vol.4, Iss.12, 2002-01, pp. : 771-778
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Blockers have a role in severe heart failure?
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Start statins stat for patients with heart failure?
Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CIBIS III: β-blockade best upfront for chronic heart failure?
Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insulin-Like Growth Factor I: An Attractive Option for Chronic Heart Failure?
Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. :